Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
NCT02734680Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in pancreatic cancer (PC) (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02734680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734680.